Magle Group releases interim report for Q2 and H1 2026 with financial results
Q2 revenue reached 146.3 MSEK but operating profit was -30.9 MSEK as the company focuses on operational restructuring and cost management.
See the latest news and media coverage for Magle Group. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare innovation developer and manufacturer
maglegroup.comLast updated
In short: Magle Group completed debt restructuring, appointed CEO, and applied to delist from Nasdaq First North.
Q2 revenue reached 146.3 MSEK but operating profit was -30.9 MSEK as the company focuses on operational restructuring and cost management.
Total revenue reached 71.7 MSEK in Q1. EBITDA was -6.6 MSEK. The company also announced future reporting dates including the Annual General Meeting on June 30, 2026.
Total revenue reached 133.8 MSEK in the first half of 2025, while the company recorded a significant net loss of -29.0 MSEK.
The company completed mergers with Amniotics and PK Chemical, strengthened CDMO services, reported positive R&D progress, and updated financial figures.
Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") announces that it has completed the restructuring of its outstanding debt and capital structure (the...
The Board of Directors of Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has today appointed Aaron Wong as Chief Executive Officer of...
The board of directors of Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), has today resolved to propose that an extraordinary general meeting...
As previously announced, Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has for some time been in constructive negotiations with bondholders representing approximately...
Track Magle Group and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Magle Group and other trending companies.